cAC 253 is a cyclic peptide derived from a receptor-binding motif that stabilizes β-turn or helical elements. Cyclization constrains backbone mobility, enhancing affinity and selectivity in binding assays. Researchers probe its interaction with neuroendocrine receptors and structural features via NMR or CD. Applications include peptide-hormone analog research, conformational analysis, and ligand-optimization work.
CAT No: R2766
cAC 253 is a synthetic carbohydrate compound derived from the active core of amylin, a peptide hormone involved in the regulation of glucose metabolism and satiety signaling. As a research-grade analog, cAC 253 is widely recognized for its ability to selectively interact with amylin receptors, thereby providing a valuable tool for dissecting the physiological and biochemical pathways influenced by amylin and related peptides. Its structural stability and receptor specificity make it an indispensable asset in experimental protocols where precise modulation of amylin signaling is required. Researchers leverage cAC 253 to investigate complex cellular processes, offering insights into metabolic regulation, neuroendocrine communication, and peptide-receptor interactions at a molecular level.
Metabolic Research: In metabolic studies, cAC 253 is frequently employed to modulate amylin receptor activity, enabling detailed exploration of glucose homeostasis and energy balance mechanisms. By acting as a selective amylin receptor antagonist, it allows researchers to delineate the downstream effects of endogenous amylin, particularly in relation to insulin secretion, glycogen storage, and appetite regulation. Utilization of this compound in in vitro and in vivo models helps clarify the interplay between amylin and other metabolic hormones, supporting the development of new hypotheses regarding metabolic disorders and energy regulation.
Neuroscience: Within the field of neuroscience, cAC 253 serves as a critical probe for studying amylin's role in the central nervous system, especially in pathways governing satiety, feeding behavior, and neuroprotection. By selectively blocking amylin receptors, it enables the dissection of neural circuits that mediate appetite suppression and food intake, offering essential data for understanding the neurochemical basis of eating behaviors. Additionally, its application in neurodegenerative research facilitates the evaluation of amylin-related signaling in neuronal survival and plasticity, furthering knowledge about peptide involvement in brain health.
Obesity and Appetite Regulation: Researchers investigating the biological underpinnings of obesity and appetite control often use cAC 253 to suppress amylin signaling, thereby elucidating the hormone's contribution to satiety and body weight maintenance. Through targeted receptor antagonism, this compound helps distinguish the specific effects of amylin from those of related peptides such as calcitonin gene-related peptide (CGRP) and insulin. Such differentiation is crucial for mapping the pathways involved in energy intake and expenditure, providing foundational data for the advancement of anti-obesity strategies and interventions.
Endocrine System Studies: In endocrine research, cAC 253 is utilized to parse the interactions between pancreatic hormones and their receptors, particularly in the context of islet cell function and hormone secretion dynamics. By blocking amylin receptor activity, scientists can investigate feedback loops and cross-talk between amylin, insulin, and glucagon, thereby enhancing the understanding of pancreatic endocrine regulation. This application is especially valuable in the study of hormone secretion patterns, receptor sensitivity, and the adaptive responses of islet cells under various physiological and experimental conditions.
Peptide-Receptor Interaction Analysis: The compound is also a preferred tool for characterizing the binding and signaling properties of amylin receptors at a molecular level. By serving as a competitive antagonist, cAC 253 aids in mapping receptor subtypes, identifying key binding domains, and elucidating conformational changes upon ligand interaction. These studies provide essential structural and functional data that inform the design of novel receptor modulators and contribute to the broader field of peptide-receptor pharmacology. The versatility and specificity of cAC 253 thus underpin its widespread adoption in research environments focused on metabolic, neurological, and endocrine systems, driving forward scientific discovery in peptide biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More